Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Chemotherapy
|
January 1, 1980
The realistic possibilities of chemotherapy for pulmonary tuberculosis in South America
L J Gonzalez Montaner, R Urbanczik
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
November 10, 2006
HIV/AIDS treatment: lessons from the tuberculosis experience
J S Montaner, A Shillington, L J Gonzalez Montaner
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|
October 1, 1994
Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus Rifampicin. Rifabutin Study Group
L J Gonzalez-Montaner, S Natal, P Yongchaiyud, et al.
Tubercle
|
December 1, 1982
Adverse effects of antituberculosis drugs causing changes in treatment
L J Gonzalez Montaner, A Dambrosi, M Manassero, et al.
Prensa Medica Argentina
|
August 1, 1971
[Hospital tuberculosis mortality. Cases in the F. J. Muñiz Hospital in the 1965-70 period]
J M Leston, L J Gonzalez Montaner, C E Gonzalez Cambaceres, et al.
Le Poumon Et Le Coeur
|
January 1, 1983
[South American blastomycosis. Apropos of new cases]
L J Gonzalez Montaner, O R Palma Beltran, E H Abbate, et al.
Scandinavian Journal of Respiratory Diseases. Supplementum
|
January 1, 1970
Psychosomatic reactions to cycloserine in the treatment of tuberculosis
J M Leston, J C Rey, L J Gonzalez Montaner, et al.
Chest
|
April 1, 1983
Pulmonary air-fluid image
L J Gonzalez Montaner, F J Chertcoff, G M Felgueras, et al.
Bulletin of the International Union Against Tuberculosis
|
January 1, 1976
Simplified short-course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months
L J Gonzalez Montaner, J M Leston, A Cetrangolo, et al.
The American Review of Respiratory Disease
|
March 1, 1989
Evaluation of an enzyme-linked immunosorbent assay (ELISA) using an IgG antibody to Mycobacterium tuberculosis antigen 5 in the diagnosis of active tuberculosis in children
S L Alde, H M Piñasco, F R Pelosi, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Chemotherapy
|
January 1, 1980
The realistic possibilities of chemotherapy for pulmonary tuberculosis in South America
L J Gonzalez Montaner, R Urbanczik
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
November 10, 2006
HIV/AIDS treatment: lessons from the tuberculosis experience
J S Montaner, A Shillington, L J Gonzalez Montaner
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|
October 1, 1994
Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus Rifampicin. Rifabutin Study Group
L J Gonzalez-Montaner, S Natal, P Yongchaiyud, et al.
Tubercle
|
December 1, 1982
Adverse effects of antituberculosis drugs causing changes in treatment
L J Gonzalez Montaner, A Dambrosi, M Manassero, et al.
Prensa Medica Argentina
|
August 1, 1971
[Hospital tuberculosis mortality. Cases in the F. J. Muñiz Hospital in the 1965-70 period]
J M Leston, L J Gonzalez Montaner, C E Gonzalez Cambaceres, et al.
Le Poumon Et Le Coeur
|
January 1, 1983
[South American blastomycosis. Apropos of new cases]
L J Gonzalez Montaner, O R Palma Beltran, E H Abbate, et al.
Scandinavian Journal of Respiratory Diseases. Supplementum
|
January 1, 1970
Psychosomatic reactions to cycloserine in the treatment of tuberculosis
J M Leston, J C Rey, L J Gonzalez Montaner, et al.
Chest
|
April 1, 1983
Pulmonary air-fluid image
L J Gonzalez Montaner, F J Chertcoff, G M Felgueras, et al.
Bulletin of the International Union Against Tuberculosis
|
January 1, 1976
Simplified short-course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months
L J Gonzalez Montaner, J M Leston, A Cetrangolo, et al.
The American Review of Respiratory Disease
|
March 1, 1989
Evaluation of an enzyme-linked immunosorbent assay (ELISA) using an IgG antibody to Mycobacterium tuberculosis antigen 5 in the diagnosis of active tuberculosis in children
S L Alde, H M Piñasco, F R Pelosi, et al.
Page
of 1